MARKET

CRBP

CRBP

Corbus Pharmaceu
NASDAQ
9.40
-0.09
-0.90%
Opening 10:50 06/08 EDT
OPEN
9.43
PREV CLOSE
9.48
HIGH
9.61
LOW
9.23
VOLUME
8.54K
TURNOVER
60.00K
52 WEEK HIGH
13.17
52 WEEK LOW
2.110
MARKET CAP
39.60M
P/E (TTM)
-0.7741
1D
5D
1M
3M
1Y
5Y
Marijuana Stock Movers For June 7, 2023
Benzinga · 23h ago
Bearish Thursday For Marijuana Stocks - iAnthus Capital Hldgs, TerrAscend Among Top Gainers
Benzinga · 6d ago
BRIEF-Corbus Pharmaceuticals Holdings Inc Files For Mixed Shelf Of Up To $100 Mln - SEC Filing
Reuters · 06/01 11:51
Marker, Nano-X top healthcare gainers, Belite, Phio among losers
Seeking Alpha · 05/31 14:05
Oppenheimer Sees Over 50% Gains in These 2 Stocks — Here’s Why They Could Soar
TipRanks · 05/31 00:45
Bearish Monday For Marijuana Stocks - Tilray Brands, HEXO Among Top Gainers
Benzinga · 05/29 21:30
Bearish Friday For Marijuana Stocks - Tilray Brands, HEXO Among Top Gainers
Benzinga · 05/26 21:30
Cannabis Stock Gainers And Losers From May 25, 2023
Benzinga · 05/25 21:30
More
About CRBP
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company. The Company is engaged in developing and commercializing therapeutics for autoimmunity, fibrosis, and cancer. Its internal development pipeline includes CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. It has developed CRB-913, a second-generation cannabinoid receptor type 1 (CB1) inverse agonist designed to treat obesity and related metabolic diseases. The CRB-913 program is in the pre-clinical-stage. It also includes Lenabasum, which is a novel, synthetic, oral molecule that selectively activates cannabinoid receptor type 2 (CB2) for the treatment of inflammation and fibrosis. Its subsidiaries include Corbus Pharmaceuticals, Inc., Corbus International Limited and Corbus Pharmaceuticals Australia Pty Ltd.

Webull offers kinds of Corbus Pharmaceuticals Holdings Inc stock information, including NASDAQ:CRBP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRBP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CRBP stock methods without spending real money on the virtual paper trading platform.